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Abstract
Background: The prevalence of asthma and atopic disease has been reported to be low in low income countries,
however helminth infections are likely to be high among these communities. The question of whether helminth
infections play a role in allergic diseases can best be addressed by intervention studies. None of the studies so far
have been based on a large scale placebo-controlled trial.
Method/Design: This study was designed to assess how intestinal helminth infections can influence the immune
response and atopic and allergic disorders in children in Indonesia. The relations between allergic outcomes and
infection and lifestyle factors will be addressed. This study was set up among school-age children in semi urban
and rural areas, located in Ende District of Flores Island, Indonesia. A randomized placebo-controlled anthelmintic
treatment trial to elucidate the impact of helminth infections on the prevalence of skin prick test (SPT) reactivity
and symptoms of allergic diseases will be performed. The children living in these semi-urban and rural areas will
be assessed for SPT to allergens before and after 1 and 2 years of treatment as the primary outcome of the study;
the secondary outcome is symptoms (asthma and atopic dermatitis); while the tertiary outcome is immune
responses (both antibody levels to allergens and cellular immune responses).
Discussion: The study will provide information on the influence of helminth infections and anthelmintic treatment
on immune response, atopy and allergic disorders.
Trial registration: Current Controlled Trials ISRCTN: ISRCTN83830814
Background
Helminth infections are highly prevalent worldwide,
with more than two billion people chronically infected
by soil transmitted helminths such as Ascaris lumbri-
coides, Trichuris trichiura and/or hookworms (Necator
americanus or Ancylostoma duodenale)[ 1 ] .T h e s e
enteric infections affect populations living in subtropical
and tropical regions of low-middle income countries,
where access to hygiene, sanitation and source of clear
water is limited [2]. The immune responses mounted to
helminth infections is characterized by T-helper type 2
(Th2), which are thought to be protective [3]. However,
there is also evidence that these parasites might enhance
their own survival by modulating the immune responses
of their host by inducing regulatory responses that dam-
pen activity of effector cells [4]. Whether all different
helminths are equally potent in inducing regulatory
responses is as yet not fully studied.
Allergens, like helminth antigens [5,6] are potent
inducers of Th2 responses [7] and it is known that aller-
gic diseases including asthma, eczema and rhinitis are
associated with Th2 inflammation [8]. However, in con-
trast to helminth infections the Th2 associated allergic
diseases, which are the most common cause of chronic
disease of childhood in high income countries, appear to
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despite the close parallels between immune responses
that characterize helminth infections and allergic dis-
eases, namely increased levels of Immunoglobulin (Ig)-E,
tissue eosinophilia and mastocytosis along with T cells
that preferentially secrete Th2 cytokines interleukin
(IL)-4, IL-5 and IL-13 [8,10-12], the clinical outcome
with respect to immediate hypersensitivity and inflam-
mation is clearly not the same [13]. Indeed, often it has
been reported that these diseases, appear to segregate
geographically [14] and several studies have reported a
negative association between the presence of helminth
infections and allergic disorders [15-18]. In experimental
animal models, several parasitic helminths have been
shown to prevent the development of eosinophilic air-
way inflammation and hyperresponsiveness [19-21].
Mechanistically, a number of immune responses have
been proposed to account for the negative association
between helminths and allergies [22]. The observations
that chronic helminth infections are associated with
higher suppressive responses, such as IL-10 [23] and
regulatory T cells [24,25] have led to the proposal that a
strong regulatory network induced by helminths might
prevent the downstream effector phase of Th2
responses, preventing excess inflammation. Moreover,
the possibility that in the presence of helminth infec-
tions, IgE antibodies generated are of lower affinity and
therefore can not lead to mast cell degranulation has
also been put forward [22].
Given that a number of studies have on the other
hand reported either no [26,27] or a positive [28,29]
association between helminths and allergies, it is very
likely that apart from the source and chronicity of infec-
tion other factors such as exposure to non-helminth
infections, and/or lifestyle play an important role in the
development of allergies. The change from traditional to
am o r e“modern” lifestyle which encompasses not only
reduced exposure to micro-organisms and parasites but
also an altered diet, in addition to changes in degree of
manual labour or inhalation of pollutants is clearly asso-
ciated with changing disease patterns [2]. It is important
to study and delineate the mechanisms that may protect
from the development of allergic diseases. It is becoming
clear that the prevalence of allergic diseases is increasing
in low to middle income countries [30] particularly in
urban centers which often show higher prevalence of
these diseases compared to rural areas [14,31,32]. It is
therefore important to use this window of opportunity
to identify risk and protective factors in cross sectional
as well as longitudinal studies.
A study that would include both helminth infections
and life style factors with respect to the development of
allergies has been planned in Indonesia. The question of
whether helminth infections play a role in allergic
diseases can best be addressed by intervention studies. So
far, one intervention study has suggested that anthelmin-
tic treatment might increase the incidence of atopy reac-
tivity [33], which is in contrast to a large scale study
where one year after treatment of intestinal helminths no
changes were recorded in allergic disorders [34]. None of
the studies have been based on a large scale placebo con-
trolled trial. Although there clearly are ethical issues with
such a design, the ethics committee of University of
Indonesia, has granted permission for a placebo con-
trolled trial providing that the community gets extensive
medical care and excludes those with intense infections.
In addition to helminth infections, the study of how
other factors may contribute to the development of aller-
gies is best achieved by longitudinal comparison of differ-
ent areas along a rural-urban gradient. Numerous studies
have analyzed the difference in the prevalence of allergic
disorders in a rural to urban gradient [35] but none so
far has done so in a longitudinal manner with the excep-
tion of one study in Ghana [31].
The ImmunoSPIN allergy project http://www.immu-
nospin.org[36] has been initiated with this aim. This
study is a randomized placebo-controlled anthelmintic
treatment trial to elucidate the impact of helminth
infections on the prevalence of atopy and allergic dis-
eases. In this study the prevalence of IgE, skin prick test
positivity and symptoms of allergic diseases such as
asthma and atopic dermatitis in school-age children will
be assessed in semi-urban and rural area in Flores, Indo-
nesia. The ImmunoSPIN allergy project will establish
the risk and protective factors and will include immune
response measurements in order to understand the
immunological mechanisms that are behind risk and
protective factors in allergy development.
Methods/Design
The study area
For this study semi-urban (Nangapanda) and rural
(Anaranda) sites located in Ende District of Flores
Island, Indonesia were selected. Nangapanda is a sub-
district situated in a coastal area with a population of
approximately 22,000 (Figure 1c.). Nangapanda is
divided into 17 villages of which those located near the
community health centre (Puskesmas), Ndeturea, Ndor-
urea1, and Ndorurea together with a population of 4650
[36] were included in the study. Local income in this
area is based on fishing and farming while some engage
in jobs at government officers with a few in the private
sector.
Anaranda is a village in sub-district of Welamosa and
is located 80 km north from Nangapanda with a popula-
tion of approximately 1,600 (Figure 1d.). The majority of
income is generated by farming. The infrastructure is
poor with no paved roads which makes the village
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able in Nangapanda, such as electricity (which is pro-
vided 12 hours per day), fuel, natural water source (not
processed water) and shops.
Preliminary surveys in 2005 and 2006 found these
areas to be endemic for geohelminths (A. lumbricoides,
hookworms and T. trichiuria).
Design
This study of schoolchildren is designed as a double-
blind randomized trial with two arms. One arm is treat-
ment with albendazole (single dose of 400 mg), while
the other arm is treatment with matching placebo (both
tablets from PT Indofarma Pharmaceutical, Bandung,
Indonesia). The treatment will be provided every three
months for a period of two years (total of 8 treatments).
The resident population of the study area were rando-
mized, by computer aided block randomization at
household level, using Random Allocation Software [37]
to either receive placebo or treatment. The treatment
will be coded with random numbers and the code will
be concealed from investigators and patients. Labels
with the study subject ID will be printed from a compu-
ter database and attached to the appropriate strip of
treatment by a separate team located in Jakarta without
the involvement of the study investigators. Treatment
codes will be unblinded by a monitoring committee
after 1 year of treatment for interim analysis of any
adverse effects that retention of anthelmintic treatment
might have on the growth of children and on the inci-
dence of allergy. If the trial continues, the final unblind-
ing of the codes will take place after two years of
treatment. At the end of the study the whole population
will be treated.
From the total study population, schoolchildren aged
5-15 years will be included in the study of allergy para-
meters at pre, 1 and 2 years post treatment. The base-
line demographic data as well as detailed questionnaires
Figure 1 The map of the study area in Flores, Indonesia. A. Indonesia map. B. Study areas in Flores island which star sign. C. Nangapanda
(semi urban area) where each dot represents one household. D. Anaranda (rural area) where each dot represents one household.
Hamid et al. BMC Infectious Diseases 2011, 11:83
http://www.biomedcentral.com/1471-2334/11/83
Page 3 of 10to delineate risk and protective factors for the develop-
ment of allergies are planned at pre treatment stage.
Skin prick testing (SPT) to allergens, International Study
of Asthma and Allergy in Childhood (ISAAC) question-
naires, stool collection for helminth load, blood sam-
pling for serology as well as whole blood culture is
planned for time points pre, 1 and 2 years post treat-
ment while exercise-induced bronchialconstriction (EIB)
will be measured at pre and two years post treatment.
Whereas SPT, ISAAC, parasitological examination as
well as serology will be performed for all study subjects,
where blood culture will be performed for children ran-
domly selected based on households. The EIB will also
be done in a subset of randomly selected children based
on helminth as well as SPT status.
Sample size
Data available from a pilot study where 102 schoolchil-
dren were skin prick tested as well as data available
from studies on other areas of Indonesia [38,39] were
used for sample size calculations. Initial prevalence of
SPT reactivity to a panel of allergens was found to be
15%. In order to find a 50% increase or decrease in SPT
in the population, and taking into account a loss to fol-
low-up of 20%, 709 individuals were needed in each
treatment arm (taking into account a power of 0.90 and
an alpha of 0.05). The reported prevalence of SPT to
aeroallergens in children rural versus urban areas in low
and middle income countries is around 10% versus 20%
[31,40]. Moreover, treatment studies have often shown a
doubling of SPT reactivity in treatment studies [4,33],
we have based our sample size calculation on a more
modest increase as the prevalence of helminth infections
is high in Anaranda and Nangapanda areas and there-
fore it might be difficult to eliminate these infections.
Information, recruitment, consent, specimen collection
and storage
The local health authorities in Ende were informed
and they gave their agreement and support for this
study. Socialization took place over a two-year period,
from 2006 to 2008. Staff members from the Puskesmas
are being fully involved and 50 community workers are
being trained for following study subjects, filling ques-
tionnaires and keeping the community well-informed
and well-engaged. Through many organized sessions,
the village heads are being involved in passing on
information about the study, including the benefits and
risks involved. The longitudinal nature is explained
and information sheets and consent forms (in Bahasa
Indonesia) were distributed. Parents or guardians gave
informed consent which was registered by signature or
thumb print. Peripheral blood will be drawn once a
year at baseline, 1 and 2 years after treatment for
immunological studies. Stool samples will be collected
once a year for intestinal helminth examination. Whole
blood cultures will be set up using samples from indi-
viduals identified in a subset of households randomly
selected from the treatment and placebo arms (Figure
2.). All blood samples (serum, cell pellet, plasma, and
whole blood), blood culture supernatants, as well as
stool samples for PCR, will be kept at -20°C and sent
to Jakarta on dry ice to be kept at -20°C (plasma, cell
plasma, blood culture supernatant) or -80°C (serum).
At baseline, we mapped all houses using GPS system.
All data that will be collected will be stored in an MS
Access database (Microsoft, Redmond, WA, USA).
1. Questionnaires and additional measurements
Additional factors that could influence allergy or atopy
will be obtained by questionnaires. The questionnaires
include the core allergy symptoms questions of ISAAC
and information on history of disease and treatment in
the last 12 months, treatment for worm infections, treat-
ment for malaria infection, bednet use, material of blan-
ket and mattress, habit to use shoes or sandals,
exposure to smoking, family history of infectious dis-
eases, BCG scar, history of immunization, history of
breast feeding and food consumption. The question-
naires will be administered to the parent or guardian of
each child under supervision of an interviewer. The
same interviewer will dispense the ISAAC questionnaire
during house to house visits. For core ISAAC question-
naires, we will show a video of asthma and rhinitis as
well as pictures for dermatitis. Additional questionnaires
will be held on socio-economic status, hygiene, ethnicity
and environment factors. These questionnaires include
information as material of the house, use of processed
water, electricity, floor material, fuel, management of
waste and exposure to pets and animals, and parent
education level. Standing height and weight without
shoes will be measured.
2. Skin prick test
Skin prick test (SPT) reactivity to common aeroallergens
[41] will be tested with extracts of Dermatophagoides
pteronyssinus and farinae (HAL Allergy Laboratories,
Leiden, The Netherlands) and Blatella germanica
(Lofarma, Milan, Italy) and to four allergens with
extracts of shrimp, soybean, peanut and fish (HAL
Allergy). A histamine positive control and a saline nega-
tive control will be used to reduce false positives and
negatives. SPT will be done on the volar side of the
child’s lower arm using skin prick lancets (Stallergènes
SA, Antony, France). The wheal size will be measured
after 15 minutes. Skin prick reactivity is be considered
positive if the longest diameter of the wheal size plus
the diameter perpendicular to it divided by two is at
least 3 mm. All SPTs in the study will be performed by
the same investigator.
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One hundred and twenty children selected on the basis
of being helminth positive or negative and SPT positive
or negative will be randomized to select equal number
of males and females that fall into the four categories:
helminth positive and SPT positive, helminth negative
and SPT negative, helminth positive and SPT negative,
helminth negative and SPT positive for spirometric test.
This test will be performed before exercise, three min-
utes after exercise and at eight minutes after exercise.
¥ 66 households do not have children 5-15 years old 
# Three monthly treatment with albendazole or placebo 
*  in a subset  
N number 
Participants 
N = 1675 children 
N = 1058 households 
Study outcome: 
1
st year post treatment 
  HH 
Treatment
 # 
1. Three  monthly 
2. Yearly  : 
-  Skin prick test 
- ISAAC  questionnaire 
-  stool collection (helminth infection) 
- Immunology  study 
- Anthropometry 
- Household  questionnaire 
3.  Pre and two years post treatment: 
Spirometry test
* 
 
Study outcome: 
2
nd year post treatment 
GPS / GIS 
Eligible with consent 
N = 1522 children 
N = 1039 HH 
¥ 
Moved out of the area 
N = 153 children, N = 19 HH 
In  
immunology study  
N = 150 HH 
In Non 
immunology study  
N = 325 HH 
1. Three  monthly 
2. Yearly  : 
- Skin  prick  test 
- ISAAC  questionnaire 
-  stool collection (helminth infection) 
- Immunology  study 
- Anthropometry 
- Household  questionnaire 
3.  Pre and two years post treatment: 
Spirometry test
* 
 
Study outcome: 
1
st year post treatment 
Study outcome: 
2
nd year post treatment 
Placebo
 # 
In  
immunology study  
N = 169 HH 
In Non 
immunology study  
N = 329 HH 
Figure 2 Profile of the ImmunoSPIN-allergy sub project http://www.immunospin.org in study areas, Flores, Indonesia.
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Page 5 of 10Each child will go through a vigorous six minutes free
running exercise in the school playground and their
heart rate will be recorded before and after exercise as a
measurement of the level of exercise stress achieved.
Spirometer calibrations will be done daily before use
according to ambient atmospheric pressure and tem-
perature. To determine whether EIB has occurred, we
will compare the highest forced expiratory volume in
one second FEV1 value from at least three acceptable
trials before exercise with the lowest FEV1 from at least
three acceptable trials after exercise. Spirometric tests
will be performed using a portable spirometer (Jaeger,
Germany) with the child sitting and with a nose clip.
EIB will be defined as positive if FEV1 falls by 15% or
more after exercise.
4. Parasitological examination
Stool examination by microscopy The formol-ether
acetate concentration method [42] will be performed on
the formalin preserved stool samples followed by micro-
scopic examination for intestinal helminth infections, as
well as protozoan infections. For the detection of hook-
worm larvae, an amount of fresh stool sample will be
cultured using filter paper soaked by distilled water
inside a sealed plastic bag according to the Harada Mori
method and the presence of larvae will be determined
by microscopic examination after seven days [43].
Stool examination by real-time PCR Stool examina-
tion by real time PCR will be done in the Netherlands
as previously described [36]. Briefly, DNA will be
extracted from unpreserved stool samples were stored at
-20°C). A multiplex real-time PCR will be used for the
specific amplification and detection of A. duodenale-, N.
americanus-, A. lumbricoides,a n dS. stercoralis DNA
[44,45]. Amplification reactions will be performed in
w h i t eP C Rp l a t e si nav o l u m eo f2 5μlw i t hP C Rb u f f e r
(Hotstar Taq master mix, QIAgen, Germany), 5 mM
MgCl2, 2.5 μgram Bovine Serum Albumin (Roche Diag-
nostics Nederland B.V., Almere, the Netherlands), 5
pmol of each A. duodenale-specific primer, and of each
N. americanus-specific primer, 2 pmol of each A. Lum-
bricoides-specific primer, 2.5 pmol of each S. stercoralis-
specific primer and 3.75 pmol of each PhHV-1-specific
primer, 1.25 pmol of each N. americanus-specific XS-
probe, A. lumbricoides-specific XS-probe, S. stercoralis-
specific double-labelled probe, and PhHV-1-specific
double-labelled probe, and 2.5 pmol of the A. duode-
nale-specific XS-probe, and 5 μl of the DNA sample.
Amplification consists of 15 min at 95°C followed by
50 cycles of 15 s at 95°C, 30 s at 60°C, and 30 s at 72°C.
Amplification, detection, and analysis will be performed
with the CFX real-time detection system (Bio-Rad
laboratories). The PCR output from this system consists
of a cycle-threshold (Ct) value, representing the amplifi-
cation cycle in which the level of fluorescent signal
exceeds the background fluorescence reflecting the para-
site-specific DNA load in the sample tested. Negative
and positive control samples are included in each ampli-
fication run.
The amplification is considered to be hampered by
faecal inhibitory factors if the expected cycle threshold
(Ct) value of 33 in the PhHV-specific PCR is increased
by more than 3.3 cycles.
5. Whole blood culture and cytokine measurements in
supernatants
Whole blood culture will be undertaken in the field stu-
dies and cytokine measurements will be done in Jakarta,
Indonesia as described previously [36], Briefly, the
heparinized blood will be diluted 1:4 with RPMI 1640
medium (Invitrogen, Breda, The Netherlands) and cul-
tured in 96 well round bottomed plates. Stimulations
will be performed with medium/control, PHA (2 μg/ml,
Wellcome Diagnostics, Darford, UK), LPS (1 ng/ml
Sigma-Aldrich, Zwijndrecht, The Netherlands), Pam3Cys
(100 ng/ml, Cayla-InvivoGen Europe, Toulouse, France),
PolyIC (50 μg/ml, Cayla-InvivoGen Europe, Toulouse,
France) and Ascaris antigen (20 μg/ml as prepared by
van Riet E et al [46]. Supernatants will be collected on
day 1 (unstimulated control, LPS, Pam3Cys) and day 3
(unstimulated control, PHA, Ascaris, PolyIC). TNF-a
and IL-10 from day 1 supernatants as well as IL-2, IL-5,
IL-10, IFN-g,a n dT N F - a for day 3 supernatants will be
analysed simultaneously using commercial Luminex
cytokine kit (Biosource, Camarillo, CA, USA) and run
on a Liquichip 200
® Workstation (Qiagen, Venlo, The
Netherlands) equipped with Liquichip analyzer software
(Qiagen, Venlo, The Netherlands).
6. Antibody measurements
Antibody IgE measurement Measurement of plasma
specific IgE to Ascaris lumbricoides antigen and to Der-
matophagoides pteronyssinus (house dust mite), Blatella
germanica, shrimp and peanut will be performed using
an ImmunoCAP 250 system (Phadia, Uppsala, Sweden)
following the manufacturer’s instructions [47]. All mea-
surement will take place in one laboratory in the
Netherlands.
Total IgE Total IgE will be measured in Jakarta, Indo-
nesia as described previously[36,48]. Briefly, maxisorp
plates (Thermo Fisher Scientific, Roskilde, Denmark)
will be coated overnight with 1/1400 diluted rabbit anti-
human IgE (Dako, Glostrup, Denmark). Plates are
blocked with phosphate buffered saline (PBS) containing
5% bovine serum albumin (BSA, Albumin Fraction V,
Boehringer, Mannheim, Germany). Sera is diluted 1/200
in PBS containing 5% fetal calf serum (FCS, Greiner
Bio-One, Alphen a/d Rijn, Netherlands). A positive stan-
dard serum containing human IgE (NIBSC, Potters Bar,
UK) are incubated on each plate. Plates will be incu-
bated for 1 hour at room temperature. After a washing
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1000 (Vector Laboratories, Burlingame, CA, USA)) and
Streptavidin Alkaline Phosphatase conjugate (1/3000
(Boehringer, Mannheim, Germany)) will be incubated
for 1 hour at room temperature. The results will be
expressed in International Units (IU).
Outcomes and case definitions
The study aims to determine whether and how helminth
infections may affect allergic disorders. The study will
therefore determine the effect that anthelmintic treat-
ment albendazole has versus placebo on SPT reactivity,
symptoms of allergic diseases and immune responses.
The primary outcome of the study is SPT; the secondary
outcome is symptoms (asthma and atopic dermatitis);
w h i l et h et e r t i a r yo u t c o m ei si m m u n er e s p o n s e s( b o t h
IgE levels to allergens and cellular immune responses
that represent both innate and adaptive immune
reactivities).
Helminth infections will be determined by the presence
of parasites detected by microscopic examination of stool
as well as by molecular (PCR-based) methods. Atopy will
be defined as either positive in SPT (≥3 mm wheal size) to
any of aeroallergens tested or the presence of allergen-spe-
cific IgE ≥ 0.35 kU/L. Symptoms of asthma and atopic der-
matitis will be assessed by modified ISAAC questionnaires
[41] that have been translated into Bahasa Indonesia and
translated back to English and adapted for use in the study
area. It has been tested in some areas in Sulawesi as well
as in study areas during pilot studies. A positive answer to
the questions (i) has your child ever had asthma? (ii) has
this asthma been diagnosed by a doctor? and (ii) has your
child ever or in the past 12 months had wheezing or whis-
tling in the chest? will be interpreted as asthma, while a
positive answer to the question (iv) has your child ever
had doctor/paramedic diagnosed allergic eczema and (v)
has your child ever had one or more skin problem accom-
panying an itchy rash? will be taken as atopic dermatitis.
In order to test the effect of helminths on bronchial
hyper-responsiveness (BHR) we will test lung function
following American Thoracic Society and European
Respiratory Society (ATS/ERS) guidelines[49] for lung
function and BHR testing [41,50,51]. FEV1 will be mea-
sured before and after 6 minutes of exercise [52] and a
fall of 15% in FEV1 is considered to indicate EIB. In
order to take into account confounding factors, data on
family structure like number of siblings, birth order will
be recorded as well as details of birth and breastfeeding,
hygiene, socioeconomic status, annual health status, and
food consumption.
Overview of plan of analyses
The baseline data will be analyzed to determine whether
helminth infections are associated with allergen specific
IgE, atopy and symptoms of asthma or eczema. Both
presence of infection and intensity of infection will be
used for logistic and linear regression analyses. Analysis
will be adjusted for confounding factors such as socio-
economic status, body mass index, age, sex and environ-
mental exposure. Additional confounders that are iden-
tified during the study will also be used. In order to
examine a general effect of parasite burden and rural
and semi-urban differences in atopy and allergy will be
compared. The effect of anthelmintic treatment on
atopy and allergy will be assessed 1 and 2 years after
treatment by analyzing prevalence as well as incidence.
The analyses will be based on intention to treat
approach. The groups in treatment and placebo arms
will be compared as well as groups in whom helminth
infection was reduced or remained unaltered irrespective
of treatment assignment and we will also look at chronic
versus acute infections, based on continuous presence of
infection or newly gained infections over the follow up
period. Individuals that are lost to follow up and indivi-
duals that are analyzed will be compared on the basis of
their baseline characteristics, age, gender, village, socioe-
conomic status and parasitic infections. A similar com-
p a r i s o nw i l la l s ob eu n d e r t a k e nt oc o m p a r et h e
characteristics of individuals in the treatment and pla-
cebo groups at inclusion into the study. Chi-square, t-
tests and Mann-Whitney tests will be used to test for
differences. For data-analyses we will use SPSS (SPSS
I n c . ,C h i c a g o ,I L ,U S A )a n dA r c G i s( E S R I ;R e d l a n d s ,
CA, USA).
To summarize, the plan is to measure the prevalence
of allergy in school-aged children in semi urban and
rural areas, and to establish their association with hel-
minth infections as well as various risk and protective
factors. By studying cellular immunological parameters,
it is also the aim to understand the immunological
mechanisms that are behind risk and protective factors
in allergy.
The analysis will be divided into six principals study
questions (Figure 3.):
1. What is the association between helminth infec-
tions and atopy and allergy symptoms?
2. What is the association of helminth infections and
immune responses?
3. What is the association between immune
responses and atopy and allergy symptoms?
4. Does the immune response change after anthel-
mintic treatment?
5. Does the prevalence of atopy and allergy symp-
toms change after anthelmintic treatment?
6. What is the role of hygiene, geographic location
and socio-economic status in helminth infection and
allergy?
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The study was approved by the Ethical Committee of
the Medical Faculty, University of Indonesia, Jakarta
(ethical clearance ref: 194/PT02.FK/Etik/2006) and has
been filed by ethics committee of the Leiden University
Medical Center, The Netherlands. The trial was regis-
tered as clinical trial ref: ISRCTN83830814. Parental
consent was obtained for children who participated in
the study. The study is reported in accordance with the
CONSORT guidelines for cluster-randomized studies.
Discussion
The prevalences of atopic disorders and asthma have
been reported to be lower in low income than in high
income countries, however these are becoming an
increasingly important public health problem, particu-
larly in urban centres of the developing world [35,53].
With the view to the increasing urbanization it is impor-
tant to have data on factors and mechanisms underlying
the development of allergic diseases in low to middle
income countries. Indonesia is a prototype of a country
in transition towards a well developed economy with
dynamic changes in lifestyle. The ImmunoSPIN project
was designed to assess how helminth infections can
influence the immune response and clinical outcome of
allergic disease and this study will compare atopy and
allergic symptoms in children living in a semi urban and
rural setting in Indonesia. The relations between allergic
outcomes and the numerous measured exposures will
be addressed.
In our study design we will use a longitudinal
approach to assess the effect of anthelmintic treatment
on prevalence, risk and protective factors in children liv-
ing in semi urban and rural environments. The labora-
tory component will explore the relative importance of
immunological mechanisms that are leading to increase
in prevalence of allergic disorders. Statistical analysis
will involve the use of strategies that link data from dif-
ferent levels (e.g. socio-economic, environmental, clinical
and immunological factors) and will use advanced statis-
tical techniques to deal with this complex mechanism.
The study has so far provided data that are shown in a
flow chart given in Figure 2. A total of 1675 children
were registered in 1058 households in study area, char-
acteristics of study population are given in table 1 with
prevalence of helminth infection in both areas. Distribu-
tion of sex and age groups are shown in (Figure 4.) in
the semi urban area which has three junior high schools
and four elementary schools, as well as in the rural area
only one elementary school. This results in larger num-
ber of older children in semi urban area than in rural
area. Some of the children exits from rural area leave
the area to go to junior high school in surrounding lar-
ger villages but not necessarily to our semi urban study
area (as the distance between our study areas is consid-
erable). These children will be skin prick tested, and
characterized via questionnaires. In addition, blood
withdrawal will allow the determination of total and
specific IgE in addition to cellular immunological
Table 1 Characteristics of the study population
Semi Urban Rural
Participants 1161 514
Age (mean, SD) 6.77 ± 3.31 5.85 ± 3.12
Sex male/female (male%) 583/578 (50.2) 270/244 (52.5)
BMI (mean, SD) 15.4 ± 2.39 14.4 ± 1.83
Parasites (%)
Any helminths 53.2 40.8
Ascaris lumbricoides 38.7 21.8
Trichuris trichiura 25.3 11.8
Hookworms 11.8 18.5
Body Mass Index (BMI) = Weight(kg)/height(m) squared. Helminth infection
was measured by microscopic examination.
Treatment
HELMINTH
thi i f t i
IMMUNE RESPONSES
Innate, Adaptive    
4
3
2 5
acute, chronic infection
ATOPY/ALLERGY
hygiene, geographic location, 
socio-economic and others factors
3
1
6
Figure 3 Conceptual of principal question study.
Figure 4 Distribution of sex and age in school children
participating in the study. Distribution of children participants in
the semi urban (Nangapanda) and the rural (Anaranda) areas.
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will be performed. After completion of the study the
whole population will be treated with adequate treat-
ment for helminth infections. This study is also unique
in that it will provide data on anthelmintic treatment
efficacy and effectiveness in a defined large population
in a developing country.
If helminth infections are proved to be associated with
reduced allergic disorders, and the mechanisms behind
such protective effect is elucidated, measures can be
taken to ensure that the vicious circle of westernization
and increased allergy is prevented; for example vaccina-
tion with microbial products and allergens. If helminths
are proved not to be associated but new factor(s) are
identified along with the immunological mechanism(s)
through which the development of allergies is affected,
then appropriate preventive measures can also be planed.
In summary the ImmunoSPIN helminth-allergy study is
the first and currently the only longitudinal study of hel-
minth and allergy in Indonesia. The study has received
enthusiastic support from the authorities in Ende and at
the regional level. At the same time, the study facilitates
the transfer of state of the art technologies in immunology,
molecular biology, epidemiology and statistics to Indonesia.
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